ARCHIVES

Cancer Groups Endorse Pazdur For FDA Commissioner.

This article is from The Cancer Letter archive.

Vol. 27 No. 03 | January 19, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Appropriations Still Hung Up

September 30, 1977

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

New NCI Grant Program Will Support Young Scientists In Innovative, “Risky” Research

May 27, 1977

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000